Shareholding disclosure

Oliver R. Baumann

Declared position

8.4%

Threshold

Crossed upwards

Timeline

Published

19.02.2022

Transaction

11.02.2022

Voting rights breakdown

Voting rights acquired8.4%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAM2I00056

Beneficial owner

Oliver R. Baumann

Declared address

Oliver R. Baumann, 8126 Zumikon

Kotierung der Aktien an der Six Swiss Exchange

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Oliver R. Baumann

Xlife Sciences AG19.02.2022TAM2I00056

Disclosure summary

Oliver R. Baumann disclosed a holding in Xlife Sciences AG on the acquisition side, published by SIX Exchange Regulation on 19.02.2022, at 8.4% of voting rights. Notice category: Single shareholder.

Disclosed position

8.4%

Voting rights acquired

Voting rights acquired8.4%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Oliver R. Baumann disclosed a holding in Xlife Sciences AG, published on 19.02.2022.

Publication date19.02.2022

Transaction date11.02.2022

Issuing companyXlife Sciences AG

Beneficial ownerOliver R. Baumann

Declared addressOliver R. Baumann, 8126 Zumikon

CategorySingle shareholder

Voting rights acquired8.4%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAM2I00056

Conditions

Kotierung der Aktien an der Six Swiss Exchange

Source: SIX Exchange Regulation · Publication date: 19.02.2022

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open